MDAI

Safety profile
Category: Entactogen, Empathogen, SSRA
Main effects: Entactogenic effects, Empathogenic effects, Euphoria
Side effects: Nausea, headache, tiredness, depression, rise in blood pressure
Health risks: Mental addiction
Important safety remarks: Cardiovascular toxicity has not been tested. As of 2013, long-term studies on this substance have not been performed, so long term effects are still UNKNOWN!

Brief overview - What is MDAI?

5,6-Methylenedioxy-2-aminoindane (MDAI) is a drug developed by David E. Nichols at Purdue University in the early 1990s. It is a highly selective serotonin releasing agent (SSRA). Like MDA and MDMA, it produces entactogenic effects but, unlike similar drugs, it results in little to no stimulant effects.